Synedgen’s Shenda Baker Selected to Provide Input in the SoCalBio W3 Forum


SoCalBio W3 Forum:Top 5 Things to Build a Successful Life Science Company

Synedgen President and Chief Operating Officer Shenda Baker PhD is one of five panelists selected to participate in the Southern California Biomedical Council Women, Work & Wisdom (W3) Forum on May 12, 2016: Top 5 Things to Build a Successful Life Science Company.

W3 is a by-invitation-only meeting of bioscience women executives and allied service providers affiliated with SoCalBio to encourage networking and mutual support among bioscience women executives and company managers. This panel discussion, sponsored by W3, invites all interested life science entrepreneurs through executives to participate in a presentation and Q&A period highlighting successful strategies for building a successful enterprise. The Southern California Biomedical Council is a nonprofit, member-supported trade association that supports and promotes life-science research, development, manufacturing, job creation and overall economic growth in the Greater Los Angeles region.

This panel will focus on the drivers and barriers to building a solid foundation for life science companies. The top five topic discussions for company survival and growth are capital investment, strategies around regulatory pathway, clinical trials and reimbursement, talent competition, operational excellence and flawless execution, and collaboration and competition.

“SoCalBio and W3 have selected very successful colleagues with a wealth of experiences that will inform attendees of the various stages involved in a life science company development. In addition, the Southern California business community has the opportunity to hear about the strategies and approaches Synedgen has used to fuel our growth and expanding product pipeline,” said Dr. Baker. “W3 is a terrific facilitator for local scientific and business networking in the biomedical community, and I am honored to participate.”